Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,402,616
-
Share change
-
+870,662
-
Total reported value
-
$96,861,638
-
Put/Call ratio
-
72%
-
Price per share
-
$3.41
-
Number of holders
-
98
-
Value change
-
-$995,213
-
Number of buys
-
43
-
Number of sells
-
45
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q3 2019
As of 30 Sep 2019,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,402,616 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., Aquilo Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Tekla Capital Management LLC, VANGUARD GROUP INC, STATE STREET CORP, Omega Fund Management, LLC, and Candriam Luxembourg S.C.A..
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.